Skip to content

Other at other companies

Popular logo
PopularBPOP
$21.34M-20.5%
KEE
Keel Infrastructure Corp. Common StockKEEL
$6.15M+2,788%
EFC
Ellington Financial Inc.EFC
$9.7M+46.8%
Kemper logo
KemperKMPR
$11.9M-28.1%
Curtiss-Wright logo
Curtiss-WrightCW
$37.78M+19.0%
Quantum Computing Inc. logo
Quantum Computing Inc.QUBT
$1.2M+450%

Other financials

Income statement

See full
Revenue$17.0M-39.3%
Operating income-$134.0M-9.8%
Net income-$128.0M-14.3%
EPS (diluted)-$1.02+10.5%

Balance sheet

See full
Cash & equivalents$201.0M+4.7%
Total debt$113.0M+88.3%
Total equity$524.0M-1.3%
Total assets$997.0M-13.8%

Cash flow

See full
Operating cash flow-$138.0M-4.5%
CapEx--100%
Free cash flow-$138.0M-3.8%

Valuation

See full
Market cap$3.62B+226%
Enterprise value$3.53B+275%
P/S15.4×+7.5×

Profitability

See full
Operating margin-168.6%-52.7pp
Net margin-156.4%-47.5pp
FCF margin-207.2%

Returns & leverage

See full
Return on equity-70%+8.4pp
Debt / equity0.2×+0.1×
Current ratio-1.3×

Where this comes from

Reported directly by Arcus Biosciences in its filing.

Tagged under the XBRL concept us-gaap:OtherSundryLiabilitiesCurrent.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's other.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arcus Biosciences's other?
Arcus Biosciences (RCUS) reported other of $10M in Q1 2026.
How has Arcus Biosciences's other changed year-over-year?
Arcus Biosciences's other decreased by 41.2% year-over-year, from $17M to $10M.
What is the long-term trend for Arcus Biosciences's other?
Over 3 years (2022 to 2025), Arcus Biosciences's other has grown at a 81.7% compound annual growth rate (CAGR), from $3M to $18M.